The purpose of this consultation, launched by Resah acting as a central purchasing body, is to acquire innovative solutions to fight against anti-microbial resistance (Radar Project). The services are defined in detail in the specification of special technical clauses (CCTP) common to all lots. With regard to lots 1 to 7, Resah acts as a central purchasing body in accordance with the so-called "intermediary" mode. In the context of lots 8 to 10 inclusive, Resah acts as central purchasing agency in accordance with the so-called "wholesaler" method within the framework of framework agreements with purchase orders

Global microbiology solution for equipment (microbial identification and rapid susceptibility testing, molecular biology) with associated services, and rapid tests for the detection of resistance and microorganisms, and software (infection surveillance and alerting, antibiotic consumption and antibiotic therapy monitoring) - Intermediate batch in costs

Antibiotic Consumption and Bacterial Resistance Monitoring and Alert Software

Microbiology PLC for rapid susceptibility identification operating on a single PLC and associated services - Intermediate batch in costs Packages

Molecular biology PLC with embedded extraction operating on a single PLC and associated services

rapid test for colistin resistance in Enterobacteriaceae, Pseudomonas and Acinetobacter by immunochromatography or colorimetry

Rapid test (immunochromatographic) Adenovirus, Rotavirus and Norovirus

rapid test (immunochromatographic) for Clostridium difficile

rapid fluid immunofluorescence test (COVID-19, RSV and influenza) with associated reader and connectable to middleware

multidrug-resistant bacteria (MDR-TBR) and emerging high-resistant bacteria (BHRE) monitoring and alerting software

Antibiotic therapy monitoring software based on the patient's pathology (patient record data) and laboratory data